Clinical trial Recruiting at 1 site Interventional Ages 4 to 17

Helping children and teens manage severe irritability, anxiety, and depression.

Official title: Psychological Assessment and Treatment of Youth Emotional and Behavioral Dysregulation

Run by Florida State University · NCT07296939 · Data updated 2026-11-12

This program will try cognitive behavioral therapy plus detailed behavioral and brain tests to see if it helps children and teens (ages 4–17) with severe irritability, anxiety, or depression.

More Depression, Anxiety trials

Quick facts

Study typeInterventional
Ages4 Years to 17 Years
SexAll
Enrollment500 (estimated)
SponsorFlorida State University
Academic / other
Locations1 site (Tallahassee, Florida)
StatusRecruiting
StartedMay 7, 2026
Main results expectedMay 31, 2027
Study endsJuly 31, 2027
Registry record updatedMay 14, 2026
Trial IDNCT07296939 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking children aged 4–17 with a principal anxiety or mood disorder or clinically impairing irritability, with at least one parent available to participate.

Probably not a fit

Children with gross neurological or sensory impairments, seizure disorders, psychosis, active suicidality, or who cannot complete procedures in English are unlikely to qualify or benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project enrolls school-aged children (4–17) with anxiety or mood disorders or clinically impairing irritability to characterize mechanisms and deliver evidence-based treatment. Participants complete a comprehensive multimodal assessment including diagnostic interviews, multi-informant behavioral ratings, and neurophysiological tasks to capture cognitive, behavioral, and psychosocial factors. Participants then receive cognitive behavioral therapy with repeated assessments throughout the study period to measure changes. The design links mechanistic measurement with treatment response to identify targets that drive severe irritability.

Why it matters

Potential benefit: If successful, this approach could reduce severe irritability and improve daily functioning and mood in affected children.

How similar studies have gone: Cognitive behavioral therapy has proven effective for youth anxiety and depression, but applying a multimodal mechanistic assessment specifically to severe irritability is a newer, less-tested approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children between the ages of 4-17 years
* (a) a principal diagnosis of an anxiety or mood disorder per DSM-5 criteria, OR (b) parent report of clinically impairing irritability, emotional dysregulation, and/or disruptive behavior in youth
* Child and parent must be able to complete consent documents, assessments, and participate in treatment in English without a translator
* At least one parent must be available and willing to participant in both phases.

Exclusion Criteria:

* Gross neurological, sensory, or motor impairment
* History of seizure disorder, psychosis, or organic brain syndrome
* Conditions requiring acute intervention, e.g., active suicidality
* Non-English speaking child or parent

Where it's running

  • Florida State University
    Tallahassee, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.